Competing commitments in clinical trials. [IRB. 2009 Sep-Oct] - PubMed

loading

Review Conflicts of interest in pain medicine: Practice patterns and relationships with industry. [Pain. 2008]
Review Conflicts of interest in pain medicine: Practice patterns and relationships with industry.
Schofferman J, Banja J. Pain. 2008 Oct 31; 139(3):494-7. Epub 2008 Sep 24.
Extend the reach of institutional review boards first, then strengthen their depth. [Am J Bioeth. 2008]
Extend the reach of institutional review boards first, then strengthen their depth.
Spike J. Am J Bioeth. 2008 Nov; 8(11):11-2.
Review Conflict of interest in human subjects research. [Crit Care Med. 2003]
Review Conflict of interest in human subjects research.
Groeger JS, Barnes M. Crit Care Med. 2003 Mar; 31(3 Suppl):S137-42.
The use of placebos in clinical trials: responsible research or unethical practice? [Conn Law Rev. 2001]
The use of placebos in clinical trials: responsible research or unethical practice?
Hoffman S. Conn Law Rev. 2001 Winter; 33(2):449-501.
A duty to deceive: placebos in clinical practice. [Am J Bioeth. 2009]
A duty to deceive: placebos in clinical practice.
Foddy B. Am J Bioeth. 2009 Dec; 9(12):4-12.

Competing commitments in clinical trials.
Competing commitments in clinical trials.
IRB. 2009 Sep-Oct ;31(5):1-6.

PubMed
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type ...
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
J Virol. 1991 Feb ;65(2):922-30.

PubMed
Complementation between avirulent Newcastle disease virus and a fusion protein g...
Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion.
J Virol. 1991 Feb ;65(2):813-22.

PubMed
Potential new treatment for patients with severe chronic hand eczema.
Potential new treatment for patients with severe chronic hand eczema.
Dermatol Nurs. 2009 Sep-Oct ;21(5):305-6.

PubMed
Weak base amines can inhibit class I MHC-restricted antigen presentation.
Weak base amines can inhibit class I MHC-restricted antigen presentation.
J Immunol. 1991 Jan 15 ;146(2):449-56.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed